Abstract
It is now a common understanding that to define a rationale for an effective therapy, an in-depth knowledge of physiology as well as pathology related to the specific issue is critical. This is the case for inositol supplementation. Inositols belong to the polyols family and form nine different stereoisomers. These molecules – mainly the stereoisomer called myo-inositol (myo-Ins) – have gained momentum during the last decades as novel promising treatment for a wide range of pathological conditions namely gynecological diseases, insulin resistance, respiratory distress syndrome in newborns, psychiatric illness, and even cancer [1]. The purpose of this editorial is meant to guide the reader through the study of the physiological role exerted by inositols, which enhances the rational therapeutic use of these molecules mainly focusing on gynecological practice.
